Sanofi Board Forces CEO Chris Viehbacher to Resign Amid Lantus Woes
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi announced that Christopher Viehbacher has resigned as CEO after its board voted unanimously to remove him. The drama comes amid serious worries over the group’s cash cow medicine, Lantus.